Suppr超能文献

[改良VAB-3联合化疗治疗卵巢IV期内胚窦瘤]

[Modified VAB-3 combination chemotherapy of stage IV endodermal sinus tumor of the ovary].

作者信息

Tsukamoto N, Imachi M, Sumioki H, Kamura T

出版信息

Gan To Kagaku Ryoho. 1984 Apr;11(4):948-51.

PMID:6202244
Abstract

A case of pure endodermal sinus tumor (EST) of the ovary with huge multiple liver metastases was treated with modified VAB-3 protocol. Serum alpha-fetoprotein (AFP) before treatment was 137,775 ng/ml. A complete clinical response was achieved with rapid shrinkage of liver metastases and normalization of serum AFP. Second-look laparotomy preformed 17 months after the start of chemotherapy revealed no evidence of disease. VAB-3 combination chemotherapy, which was proved to be very effective in the treatment of metastatic testicular cancer, also seems to be effective in the treatment of advanced EST of the ovary. This is believed to be the first detailed report of the successful management of advanced EST of the ovary.

摘要

1例卵巢纯内胚窦瘤(EST)伴多发巨大肝转移患者接受改良VAB - 3方案治疗。治疗前血清甲胎蛋白(AFP)为137,775 ng/ml。随着肝转移灶迅速缩小及血清AFP恢复正常,取得了完全的临床缓解。化疗开始17个月后进行的二次剖腹探查未发现疾病迹象。VAB - 3联合化疗在转移性睾丸癌治疗中已被证明非常有效,在晚期卵巢EST治疗中似乎也有效。这被认为是关于晚期卵巢EST成功治疗的首份详细报告。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验